|
RBS Global Big Pharma Exchange Traded Notes due 10/25/2041
Ticker Symbol: DRGS* CUSIP: 78009P135 Exchange: NYSEA
* NOTE: This security is no longer trading as of 7/07/2015
Company's Online Profile
BUSINESS: RBS Global Big Pharma Exchange Traded Notes (ETNs) due October 25, 2041 are unsecured and unsubordinated obligations of The Royal Bank of Scotland plc, and are fully and unconditionally guaranteed by The Royal Bank of Scotland Group plc. INVESTMENT OBJECTIVE: The RBS Global Big Pharma ETNs are designed for investors who seek exposure to the NYSE Arca Equal Weighted Pharmaceutical Total Return Index. INDEX DESCRIPTION: The NYSE Arca Equal Weighted Pharmaceutical Total Return Index is comprised of equity securities of a cross-section of companies involved in various phases of development, production and marketing of pharmaceuticals, with the component securities represented in approximately equal dollar amounts. In addition, the Index is a total return index, which means that the level of the Index takes into account the cash dividends paid, if any, on the Index components. RETURNS AND MATURITY: The return on the Securities may be positive or negative and is directly linked to the performance of the NYSE Arca Equal Weighted Pharmaceutical Total Return Index, which is based on performance of the securities comprising the Index. If your ETNs have not previously been repurchased or redeemed by RBS plc, at maturity, October 25, 2041, you will receive a cash payment equal to the daily redemption value of your ETNs on the final valuation date. REDEMPTION AND FEES: The Royal Bank of Scotland plc shall repurchase any ETNs offered by investors (provided that at least 20,000 ETNs are offered for repurchase) or shall redeem any ETNs called by it for redemption at its option. If you elect to offer your ETNs for repurchase and the requirements for acceptance by RBS plc are met, you will receive a cash payment on the applicable repurchase date in an amount equal to the daily redemption value on the relevant valuation date. The annual investor fee will be equal to 0.60% per annum accrued on a daily basis. For calculations of fees and any further information on this ETN click on the Link to IPO Prospectus provided.
|
Notes: June 22, 2015 -- The Royal Bank of Scotland plc (RBS plc) announced today that it has elected to redeem the thirteen exchange traded notes (the ETNs) on or about July 7, 2015: RBS plc previously disclosed in the related pricing supplement for each ETN its expectation that it would redeem the ETNs. The expected redemption is a consequence of RBS plc's exit of the structured retail investor products business. RBS plc expects to provide notice of redemption to the trustee and to the holders of the ETNs via The Depository Trust Company on June 29, 2015. The daily redemption value of each ETN will be determined on its applicable valuation date. Payment of the daily redemption value of each ETN is expected to be made on the sixth business day following the date of the notice of redemption, which is expected to be July 7, 2015. Accordingly, the last day of trading for each ETN is expected to be July 6, 2015.
|
IPO - 10/21/2011 -
Link to IPO Prospectus
Micro Cap Stock -
Market Value $4.0 Million
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: RBS American Headquarters, 600 Washington Boulevard, Stamford, CT 06901 |
| Main Phone Number |
203-897-2700 |
| Fax Number |
Not Available |
| Investor Contact
|
855-727-3877
|
| Toll Free Phone Number |
855-727-3877 |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
